{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:12:57Z","timestamp":1787065977764,"version":"build-2736575974"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,10]],"date-time":"2025-08-10T00:00:00Z","timestamp":1754784000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,8,10]],"date-time":"2025-08-10T00:00:00Z","timestamp":1754784000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004731","name":"Natural Science Foundation of Zhejiang Province","doi-asserted-by":"publisher","award":["LTGY24H120005"],"award-info":[{"award-number":["LTGY24H120005"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017594","name":"Medical Science and Technology Project of Zhejiang Province","doi-asserted-by":"publisher","award":["2022KY908"],"award-info":[{"award-number":["2022KY908"]}],"id":[{"id":"10.13039\/501100017594","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eye and Vis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>This retrospective study aimed to identify risk factors for subretinal fibrosis (SF) and evaluate the response to anti-vascular endothelial growth factor (anti-VEGF) therapy in patients with myopic choroidal neovascularization (mCNV), with a specific focus on the role of dilated choroidal vessels (DCVs) in disease progression.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this retrospective study, patients with high myopia (spherical equivalent\u00a0&lt;\u00a0\u22126.0 D, pathological myopia, Asian ethnicity) and active mCNV lesions, diagnosed between 2021 to 2023, were evaluated. The location of DCVs and mCNV was assessed, and macular thickness, submacular choroid thickness, best-corrected visual acuity, CNV area, and flow density were measured at baseline and during follow-up. The presence of posterior staphyloma was evaluated at baseline. SF around the mCNV was evaluated lesions during follow-up. The time to SF detection was recorded using survival analysis. Risk factors for SF were analyzed using Kaplan\u2013Meier and multivariable Cox regression analyses.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 46 eyes from 46 patients were included, with a mean age of 54.17\u2009\u00b1\u200914.37\u00a0years, and a baseline spherical equivalent of 12.36\u2009\u00b1\u20093.21\u00a0D. The logarithm of the minimum angle of resolution for the mean visual acuity was 0.70 (0.40\u20131.30), and the mean macular thickness was 313.11\u2009\u00b1\u200963.57\u00a0\u03bcm at baseline. DCV was detected in 29 of the 46 eyes (63.0%), and the median time to detect SF was 43.41 [95% confidence interval (CI): 37.27\u201349.55] months. Multivariable Cox regression analysis identified submacular DCV [hazard ratio (HR): 14.93, 95% CI: 5.72\u201338.91,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001) and absence of posterior staphyloma (HR: 43.48, 95% CI: 12.15\u2013156.32,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.002) as independent predictors of SF. The presence of DCV under the fovea compared to the peripheral zone achieved a poorer therapeutic response and was prone to progress to SF after anti-VEGF therapy (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.041).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Submacular DCV is associated with poor therapeutic response to anti-VEGF therapy and an increased risk of SF in patients with mCNV.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s40662-025-00450-4","type":"journal-article","created":{"date-parts":[[2025,8,9]],"date-time":"2025-08-09T23:02:19Z","timestamp":1754780539000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Myopic choroidal neovascularization with dilated choroid vessels is prone to progression into subretinal fibrosis following anti-vascular endothelial growth factor therapy: a retrospective study"],"prefix":"10.1186","volume":"12","author":[{"given":"Xiangjun","family":"She","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiwei","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wangjing","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shixin","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suyan","family":"Shan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiwei","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,10]]},"reference":[{"issue":"4","key":"450_CR1","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1016\/S0161-6420(01)01024-7","volume":"109","author":"J Vongphanit","year":"2002","unstructured":"Vongphanit J, Mitchell P, Wang JJ. Prevalence and progression of myopic retinopathy in an older population. Ophthalmology. 2002;109(4):704\u201311.","journal-title":"Ophthalmology"},{"issue":"6","key":"450_CR2","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1097\/APO.0000000000000234","volume":"5","author":"YL Wong","year":"2016","unstructured":"Wong YL, Saw SM. Epidemiology of pathologic myopia in asia and worldwide. Asia Pac J Ophthalmol (Phila). 2016;5(6):394\u2013402.","journal-title":"Asia Pac J Ophthalmol (Phila)"},{"issue":"1","key":"450_CR3","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.ajo.2013.08.010","volume":"157","author":"TY Wong","year":"2014","unstructured":"Wong TY, Ferreira A, Hughes R, Carter G, Mitchell P. Epidemiology and disease burden of pathologic myopia and myopic choroidal neovascularization: an evidence-based systematic review. Am J Ophthalmol. 2014;157(1):9\u201325.e12.","journal-title":"Am J Ophthalmol"},{"issue":"8","key":"450_CR4","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1016\/j.ophtha.2009.11.003","volume":"117","author":"K Hayashi","year":"2010","unstructured":"Hayashi K, Ohno-Matsui K, Shimada N, Moriyama M, Kojima A, Hayashi W, et al. Long-term pattern of progression of myopic maculopathy: a natural history study. Ophthalmology. 2010;117(8):1595\u2013611, 1611.e1\u20134.","journal-title":"Ophthalmology"},{"issue":"8","key":"450_CR5","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1016\/S0161-6420(96)30515-0","volume":"103","author":"SY Cohen","year":"1996","unstructured":"Cohen SY, Laroche A, Leguen Y, Soubrane G, Coscas GJ. Etiology of choroidal neovascularization in young patients. Ophthalmology. 1996;103(8):1241\u20134.","journal-title":"Ophthalmology"},{"key":"450_CR6","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.preteyeres.2017.10.005","volume":"63","author":"K Ohno-Matsui","year":"2018","unstructured":"Ohno-Matsui K, Ikuno Y, Lai TYY, Gemmy Cheung CM. Diagnosis and treatment guideline for myopic choroidal neovascularization due to pathologic myopia. Prog Retin Eye Res. 2018;63:92\u2013106.","journal-title":"Prog Retin Eye Res"},{"issue":"12","key":"450_CR7","doi-asserted-by":"publisher","first-page":"2450","DOI":"10.1097\/IAE.0000000000000632","volume":"35","author":"JM Ruiz-Moreno","year":"2015","unstructured":"Ruiz-Moreno JM, Montero JA, Araiz J, Arias L, Garcia-Layana A, Carneiro A, et al. Intravitreal anti-vascular endothelial growth factor therapy for choroidal neovascularization secondary to pathologic myopia: six years outcome. Retina. 2015;35(12):2450\u20136.","journal-title":"Retina"},{"issue":"1","key":"450_CR8","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1097\/IAE.0000000000003290","volume":"42","author":"J Ruiz-Medrano","year":"2022","unstructured":"Ruiz-Medrano J, Almazan-Alonso E, Flores-Moreno I, Puertas M, Garc\u00eda-Zamora M, Ruiz-Moreno JM. Relationship between myopic choroidal neovascularization activity and perforating scleral vessels in high myopia. Retina. 2022;42(1):204\u20139.","journal-title":"Retina"},{"issue":"8","key":"450_CR9","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1097\/IAE.0b013e318240a516","volume":"32","author":"SY Cohen","year":"2012","unstructured":"Cohen SY, Oubraham H, Uzzan J, Dubois L, Tadayoni R. Causes of unsuccessful ranibizumab treatment in exudative age-related macular degeneration in clinical settings. Retina. 2012;32(8):1480\u20135.","journal-title":"Retina"},{"issue":"3","key":"450_CR10","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1016\/j.ophtha.2013.10.019","volume":"121","author":"E Daniel","year":"2014","unstructured":"Daniel E, Toth CA, Grunwald JE, Jaffe GJ, Martin DF, Fine SL, et al. Risk of scar in the comparison of age-related macular degeneration treatments trials. Ophthalmology. 2014;121(3):656\u201366.","journal-title":"Ophthalmology"},{"issue":"11","key":"450_CR11","doi-asserted-by":"publisher","first-page":"2140","DOI":"10.1097\/IAE.0000000000001043","volume":"36","author":"SJ Ahn","year":"2016","unstructured":"Ahn SJ, Park KH, Woo SJ. Subretinal fibrosis after antivascular endothelial growth factor therapy in eyes with myopic choroidal neovascularization. Retina. 2016;36(11):2140\u20139.","journal-title":"Retina"},{"issue":"1","key":"450_CR12","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1136\/bjophthalmol-2019-315763","volume":"105","author":"H Xiao","year":"2021","unstructured":"Xiao H, Zhao X, Li S, Sun L, Xin W, Wang Z, et al. Risk factors for subretinal fibrosis after anti-VEGF treatment of myopic choroidal neovascularisation. Br J Ophthalmol. 2021;105(1):103\u20138.","journal-title":"Br J Ophthalmol"},{"issue":"10","key":"450_CR13","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1136\/bjophthalmol-2021-318970","volume":"106","author":"S Xie","year":"2022","unstructured":"Xie S, Du R, Fang Y, Onishi Y, Igarashi T, Takahashi H, et al. Dilated choroidal veins and their role in recurrences of myopic macular neovascularisations. Br J Ophthalmol. 2022;106(10):1429\u201335.","journal-title":"Br J Ophthalmol"},{"issue":"5","key":"450_CR14","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1111\/ceo.13507","volume":"47","author":"S Li","year":"2019","unstructured":"Li S, Ding X, Zhang J, Lu L. Two different initial treatment regimens of ranibizumab in myopic choroidal neovascularization: 12-month results from a randomized controlled study-Response. Clin Exp Ophthalmol. 2019;47(5):685\u20136.","journal-title":"Clin Exp Ophthalmol"},{"issue":"13","key":"450_CR15","doi-asserted-by":"publisher","first-page":"9555","DOI":"10.1167\/iovs.11-8076","volume":"52","author":"X Ding","year":"2011","unstructured":"Ding X, Li J, Zeng J, Ma W, Liu R, Li T, et al. Choroidal thickness in healthy Chinese subjects. Invest Ophthalmol Vis Sci. 2011;52(13):9555\u201360.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"450_CR16","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.ajo.2022.09.008","volume":"246","author":"KX Cheong","year":"2023","unstructured":"Cheong KX, Cheung CMG, Teo KYC. Review of fibrosis in neovascular age-related macular degeneration. Am J Ophthalmol. 2023;246:192\u2013222.","journal-title":"Am J Ophthalmol"},{"issue":"5","key":"450_CR17","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1097\/IAE.0000000000002970","volume":"41","author":"S Xie","year":"2021","unstructured":"Xie S, Fang Y, Du R, Onishi Y, Yokoi T, Moriyama M, et al. Role of dilated subfoveal choroidal veins in eyes with myopic macular neovascularization. Retina. 2021;41(5):1063\u201370.","journal-title":"Retina"},{"issue":"3","key":"450_CR18","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/j.ophtha.2013.10.023","volume":"121","author":"S Wolf","year":"2014","unstructured":"Wolf S, Balciuniene VJ, Laganovska G, Menchini U, Ohno-Matsui K, Sharma T, et al. RADIANCE: a randomized controlled study of ranibizumab in patients with choroidal neovascularization secondary to pathologic myopia. Ophthalmology. 2014;121(3):682\u201392.e2.","journal-title":"Ophthalmology"},{"issue":"11","key":"450_CR19","doi-asserted-by":"publisher","first-page":"2292","DOI":"10.1016\/j.ophtha.2013.03.046","volume":"120","author":"S Rofagha","year":"2013","unstructured":"Rofagha S, Bhisitkul RB, Boyer DS, Sadda SR, Zhang K, SEVEN-UP Study Group. Seven-year outcomes in ranibizumab-treated patients in ANCHOR, MARINA, and HORIZON: a multicenter cohort study (SEVEN-UP). Ophthalmology. 2013;120(11):2292\u20139.","journal-title":"Ophthalmology"},{"issue":"9","key":"450_CR20","doi-asserted-by":"publisher","first-page":"1798","DOI":"10.1016\/j.ophtha.2014.03.035","volume":"121","author":"K Ohno-Matsui","year":"2014","unstructured":"Ohno-Matsui K. Proposed classification of posterior staphylomas based on analyses of eye shape by three-dimensional magnetic resonance imaging and wide-field fundus imaging. Ophthalmology. 2014;121(9):1798\u2013809.","journal-title":"Ophthalmology"},{"issue":"1","key":"450_CR21","doi-asserted-by":"publisher","first-page":"14689","DOI":"10.1038\/s41598-019-51268-9","volume":"9","author":"H Matsumoto","year":"2019","unstructured":"Matsumoto H, Kishi S, Mukai R, Akiyama H. Remodeling of macular vortex veins in pachychoroid neovasculopathy. Sci Rep. 2019;9(1):14689.","journal-title":"Sci Rep"},{"issue":"10","key":"450_CR22","doi-asserted-by":"publisher","first-page":"6046","DOI":"10.1167\/iovs.12-10161","volume":"53","author":"K Ohno-Matsui","year":"2012","unstructured":"Ohno-Matsui K, Akiba M, Modegi T, Tomita M, Ishibashi T, Tokoro T, et al. Association between shape of sclera and myopic retinochoroidal lesions in patients with pathologic myopia. Invest Ophthalmol Vis Sci. 2012;53(10):6046\u201361.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"450_CR23","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1111\/ceo.14178","volume":"51","author":"JH Hung","year":"2023","unstructured":"Hung JH, Yang CM, Yang CH, Ho TC, Lai TT, Hsieh YT. Dilated choroidal vascular channels in pachychoroid neovasculopathy. Clin Exp Ophthalmol. 2023;51(1):44\u201357.","journal-title":"Clin Exp Ophthalmol"},{"issue":"4","key":"450_CR24","first-page":"481","volume":"24","author":"H Ohkuma","year":"1983","unstructured":"Ohkuma H, Ryan SJ. Vascular casts of experimental subretinal neovascularization in monkeys. Invest Ophthalmol Vis Sci. 1983;24(4):481\u201390.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"11","key":"450_CR25","doi-asserted-by":"publisher","first-page":"7290","DOI":"10.1167\/iovs.12-10371","volume":"53","author":"K Ohno-Matsui","year":"2012","unstructured":"Ohno-Matsui K, Akiba M, Ishibashi T, Moriyama M. Observations of vascular structures within and posterior to sclera in eyes with pathologic myopia by swept-source optical coherence tomography. Invest Ophthalmol Vis Sci. 2012;53(11):7290\u20138.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"9","key":"450_CR26","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1016\/j.ophtha.2006.11.034","volume":"114","author":"M Moriyama","year":"2007","unstructured":"Moriyama M, Ohno-Matsui K, Futagami S, Yoshida T, Hayashi K, Shimada N, et al. Morphology and long-term changes of choroidal vascular structure in highly myopic eyes with and without posterior staphyloma. Ophthalmology. 2007;114(9):1755\u201362.","journal-title":"Ophthalmology"},{"issue":"12","key":"450_CR27","doi-asserted-by":"publisher","first-page":"7637","DOI":"10.1167\/iovs.13-12981","volume":"54","author":"A Pedinielli","year":"2013","unstructured":"Pedinielli A, Souied EH, Perrenoud F, Leveziel N, Caillaux V, Querques G. In vivo visualization of perforating vessels and focal scleral ectasia in pathological myopia. Invest Ophthalmol Vis Sci. 2013;54(12):7637\u201343.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"450_CR28","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.ajo.2013.02.012","volume":"156","author":"SB Bloch","year":"2013","unstructured":"Bloch SB, Lund-Andersen H, Sander B, Larsen M. Subfoveal fibrosis in eyes with neovascular age-related macular degeneration treated with intravitreal ranibizumab. Am J Ophthalmol. 2013;156(1):116\u201324.e1.","journal-title":"Am J Ophthalmol"}],"container-title":["Eye and Vision"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40662-025-00450-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40662-025-00450-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40662-025-00450-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T16:42:25Z","timestamp":1757349745000},"score":1,"resource":{"primary":{"URL":"https:\/\/eandv.biomedcentral.com\/articles\/10.1186\/s40662-025-00450-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,10]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["450"],"URL":"https:\/\/doi.org\/10.1186\/s40662-025-00450-4","relation":{},"ISSN":["2326-0254"],"issn-type":[{"value":"2326-0254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,10]]},"assertion":[{"value":"10 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study procedures adhered to the tenets of the Declaration of Helsinki and were conducted in compliance with the Ethics Committee of Eye Hospital of Wenzhou Medical University (H2022-010-K-10-01).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"32"}}